Carol Ann Wallace, MD

Following this she was in private practice pediatrics and rheumatology until she joined the University of Washington and Children's Hospital and Regional Medical Center in 1984.   Dr. Wallace’s main focus has been the aggressive treatment of Juvenile Idiopathic Arthritis (JIA) and other Pediatric Rheumatic Diseases.  She has published many of the sentinel studies of the use of methotrexate in the treatment of JIA. Dr. Wallace is the Principal Investigator for an NIH funded clinical trial: Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis. She is also the co-principal investigator for a National Collaborative Study of Autologous Stem-Cell Transplantation for Severe Pediatric Rheumatologic Diseases, and participates in many multicenter clinical trials of new agents for the treatment of JIA.  With remission of disease as the goal of treatment, Dr. Wallace led an effort to develop and validate an international consensus definition for remission of JIA. Dr. Wallace has served on the Pediatric Rheumatology Sub-board for the American Board of Pediatrics, sub-committees of the American College of Rheumatology, has been on the Advisory Committee of the Pediatric Rheumatology Collaborative Study Group and is the immediate past-Chair of the Childhood Arthritis and Rheumatology Research Alliance.